248 related articles for article (PubMed ID: 2211567)
1. A double-blind, controlled trial in primary care patients with generalized anxiety: a comparison between buspirone and oxazepam.
Strand M; Hetta J; Rosen A; Sörensen S; Malmström R; Fabian C; Marits K; Vetterskog K; Liljestrand AG; Hegen C
J Clin Psychiatry; 1990 Sep; 51 Suppl():40-5. PubMed ID: 2211567
[TBL] [Abstract][Full Text] [Related]
2. Buspirone in the management of major depression: a placebo-controlled comparison.
Fabre LF
J Clin Psychiatry; 1990 Sep; 51 Suppl():55-61. PubMed ID: 2211570
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of buspirone in generalized anxiety disorder with coexisting mild depressive symptoms.
Sramek JJ; Tansman M; Suri A; Hornig-Rohan M; Amsterdam JD; Stahl SM; Weisler RH; Cutler NR
J Clin Psychiatry; 1996 Jul; 57(7):287-91. PubMed ID: 8666569
[TBL] [Abstract][Full Text] [Related]
4. Buspirone in depressed outpatients: a controlled study.
Rickels K; Amsterdam J; Clary C; Hassman J; London J; Puzzuoli G; Schweizer E
Psychopharmacol Bull; 1990; 26(2):163-7. PubMed ID: 2236452
[TBL] [Abstract][Full Text] [Related]
5. Abecarnil for the treatment of generalized anxiety disorder: a placebo-controlled comparison of two dosage ranges of abecarnil and buspirone.
Pollack MH; Worthington JJ; Manfro GG; Otto MW; Zucker BG
J Clin Psychiatry; 1997; 58 Suppl 11():19-23. PubMed ID: 9363044
[TBL] [Abstract][Full Text] [Related]
6. Deramciclane in the treatment of generalized anxiety disorder: a placebo-controlled, double-blind, dose-finding study.
Naukkarinen H; Raassina R; Penttinen J; Ahokas A; Jokinen R; Koponen H; Lepola U; Kanerva H; Lehtonen L; Pohjalainen T; Partanen A; Mäki-Ikola O; Rouru J;
Eur Neuropsychopharmacol; 2005 Dec; 15(6):617-23. PubMed ID: 15949921
[TBL] [Abstract][Full Text] [Related]
7. A double-blind, placebo-controlled study comparing the efficacy and safety of ipsapirone versus lorazepam in patients with generalized anxiety disorder: a prospective multicenter trial.
Cutler NR; Sramek JJ; Keppel Hesselink JM; Krol A; Roeschen J; Rickels K; Schweizer E
J Clin Psychopharmacol; 1993 Dec; 13(6):429-37. PubMed ID: 7907097
[TBL] [Abstract][Full Text] [Related]
8. Gepirone extended-release treatment of anxious depression: evidence from a retrospective subgroup analysis in patients with major depressive disorder.
Alpert JE; Franznick DA; Hollander SB; Fava M
J Clin Psychiatry; 2004 Aug; 65(8):1069-75. PubMed ID: 15323591
[TBL] [Abstract][Full Text] [Related]
9. Buspirone in the long-term treatment of generalized anxiety disorder.
Feighner JP
J Clin Psychiatry; 1987 Dec; 48 Suppl():3-6. PubMed ID: 3320034
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of the 5-HT1A agonist, buspirone hydrochloride, in migraineurs with anxiety: a randomized, prospective, parallel group, double-blind, placebo-controlled study.
Lee ST; Park JH; Kim M
Headache; 2005 Sep; 45(8):1004-11. PubMed ID: 16109114
[TBL] [Abstract][Full Text] [Related]
11. Randomized, single-blind, trial of sertraline and buspirone for treatment of elderly patients with generalized anxiety disorder.
Mokhber N; Azarpazhooh MR; Khajehdaluee M; Velayati A; Hopwood M
Psychiatry Clin Neurosci; 2010 Apr; 64(2):128-33. PubMed ID: 20132529
[TBL] [Abstract][Full Text] [Related]
12. Buspirone in major depression: a controlled study.
Rickels K; Amsterdam JD; Clary C; Puzzuoli G; Schweizer E
J Clin Psychiatry; 1991 Jan; 52(1):34-8. PubMed ID: 1988416
[TBL] [Abstract][Full Text] [Related]
13. Concurrent use of buspirone in anxious patients during withdrawal from alprazolam therapy.
Udelman HD; Udelman DL
J Clin Psychiatry; 1990 Sep; 51 Suppl():46-50. PubMed ID: 2211568
[TBL] [Abstract][Full Text] [Related]
14. Randomized, placebo-controlled trial of risperidone for acute treatment of bipolar anxiety.
Sheehan DV; McElroy SL; Harnett-Sheehan K; Keck PE; Janavs J; Rogers J; Gonzalez R; Shivakumar G; Suppes T
J Affect Disord; 2009 Jun; 115(3):376-85. PubMed ID: 19042026
[TBL] [Abstract][Full Text] [Related]
15. A placebo-controlled study of enciprazine in the treatment of generalized anxiety disorder: a preliminary report.
Schweizer E; Rickels K; Csanalosi I; London J; Turner D
Psychopharmacol Bull; 1990; 26(2):215-7. PubMed ID: 2236459
[TBL] [Abstract][Full Text] [Related]
16. Treatment of generalized anxiety disorder: preliminary clinical experience with buspirone.
Petracca A; Nisita C; McNair D; Melis G; Guerani G; Cassano GB
J Clin Psychiatry; 1990 Sep; 51 Suppl():31-9. PubMed ID: 2211564
[TBL] [Abstract][Full Text] [Related]
17. A double-blind comparison of buspirone and diazepam in outpatients with generalized anxiety disorder.
Feighner JP; Merideth CH; Hendrickson GA
J Clin Psychiatry; 1982 Dec; 43(12 Pt 2):103-8. PubMed ID: 6130066
[TBL] [Abstract][Full Text] [Related]
18. Controlled comparison of buspirone and oxazepam in generalized anxiety.
Ansseau M; Papart P; Gérard MA; von Frenckell R; Franck G
Neuropsychobiology; 1990-1991; 24(2):74-8. PubMed ID: 2134114
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and safety of mixed amphetamine salts extended release (Adderall XR) in the management of attention-deficit/hyperactivity disorder in adolescent patients: a 4-week, randomized, double-blind, placebo-controlled, parallel-group study.
Spencer TJ; Wilens TE; Biederman J; Weisler RH; Read SC; Pratt R
Clin Ther; 2006 Feb; 28(2):266-79. PubMed ID: 16678648
[TBL] [Abstract][Full Text] [Related]
20. Therapeutic effects and effects on actual driving performance of chronically administered buspirone and diazepam in anxious outpatients.
van Laar MW; Volkerts ER; van Willigenburg AP
J Clin Psychopharmacol; 1992 Apr; 12(2):86-95. PubMed ID: 1573045
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
